Enko Chem, Inc. announced that it will issue 16,459,544 series C preferred shares at issue price of $4.8604 per share for the gross proceeds $79,999,967.658 in funding on July 15, 2022. The shares will be convertible in common shares at a price of $4.8604 per share. The company will receive $69,493,377 pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.21 AUD | 0.00% | +1.56% | -0.19% |
Feb. 01 | Transcript : Nufarm Limited - Shareholder/Analyst Call | |
2023 | Australian Shares Surge After Weaker-than-Expected US Inflation Data | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.19% | 1.31B | |
+3.34% | 3.67B | |
-20.60% | 2.14B | |
-6.63% | 1.99B | |
+5.93% | 1.94B | |
+0.77% | 1.72B | |
+5.69% | 1.21B | |
-18.21% | 1.08B | |
-2.47% | 1.01B | |
-8.04% | 906M |
- Stock Market
- Equities
- NUF Stock
- News Nufarm Limited
- Enko Chem, Inc. announced that it expects to receive $79.999968 million in funding